GDLS expects to deliver a prototype armed ARV-30 to the USMC for trials in 2025 following USMC directed and company-led tests and demonstrations of the C4/UAS ARV prototype in 2024.
the plans and timing of presentation of first-in-human data from ARV-102 and the company’s belief that such data will highlight the potential value that its PROTAC degraders may offer patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback